$ACN

Unruch Joel sold $1.7M of ACN

Unruch Joel (General Counsel/Corp Secretary) sold 10,498 shares of Accenture plc (ACN) at an average of $162.98 ($160.86–$165.16, $1.71M total) across 5 trades on 2026-07-30 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Unruch Joel
Published Jul 31, 2026, 8:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 8:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ACN
Neutral
medium confidence
Mentioned
$ACN
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACNNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale size, price range, and post-transaction holdings by the company’s General Counsel/Corp Secretary under a 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 pre-arrangement reduces the likelihood of a fundamental signal.

03

What to watch

Because the sale is explicitly under a 10b5-1 plan, the informational content is usually lower than discretionary selling; also, the article does not state any change in business outlook.

Relevance 5/10Novelty 3/10Timing: filed 2026-07-31 after 2026-07-30 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Accenture plc (ACN).

Company-level read

Ticker impact

$ACNNeutralMedium confidence
Context

Accenture insider Form 4 shows General Counsel Joel Unruch sold 10,498 shares on 2026-07-30 under a 10b5-1 plan for about $1.71M.

Expected impact

Limited, likely no sustained price impact unless accompanied by other disclosures.

Evidence & confidence

The filing is a scheduled open-market sale by an officer under a pre-arranged 10b5-1 plan; the article provides no new operational, financial, or regulatory catalyst.

Market effects

No clear sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Insider sales can still reflect private liquidity needs or tax planning, but if repeated at elevated frequency it can be interpreted as caution by some traders.

Key entities

  • Accenture plc

    Subject of the Form 4 insider transaction disclosure.

  • Unruch Joel

    General Counsel/Corp Secretary who sold shares under a 10b5-1 plan.

Related articles

$ACNMed

Accenture was awarded a $100m, three-year extension by Australia’s Digital Health Agency to continue as the national…

Accenture was awarded a $100m, three-year extension by Australia’s Digital Health Agency to continue as the national infrastructure operator for the My Health Record system, according to the article. The original eight-year contract was reportedly worth over $500m and had a prior $42.7m two-year extension to June 2022. The new term runs to 2025.

$ACNMed

Accenture Acquires IBM Stake in UniCredit Tech Venture

Accenture (NYSE: ACN) will buy IBM’s (NYSE: IBM) majority stake in a joint venture with UniCredit to modernize UniCredit’s IT across 13 European markets. UniCredit will keep a minority stake. Accenture will run operations after closing, while IBM will continue as a technology supplier. Deal is subject to regulatory approvals; no financial terms disclosed.

$ACNMed

Accenture Takes Over IBM’s Stake In Technology JV With UniCredit

Accenture (ACN) will buy IBM’s controlling stake in a technology joint venture with UniCredit (UCG) that runs major IT operations for the bank, with UniCredit keeping a minority interest. Accenture will take primary operational responsibility after regulatory approvals and employee consultations. IBM will exit equity but continue as a technology supplier, including IBM Z platforms and software.

$ACNMed

Accenture buys IBM's stake in UniCredit Tech JV

Accenture will acquire IBM’s 51% stake in V-TServices, a tech JV managing UniCredit’s banking infrastructure across 13 European markets, according to Tech Times and company announcements. Accenture becomes co-owner and operating partner to deliver cloud, data, and AI services. IBM will continue supplying IBM Z platforms pending regulatory approvals.

$ACNMed

Unicredit S.P.A., Accenture plc and International Business Machines Corporation Collaborate to Build Europe?S Next-Generation Banking Platform

UniCredit S.p.A. said it entered a long-term collaboration with Accenture plc and IBM to build a next-generation banking technology platform across its 13 European markets. Accenture will buy a majority stake in the UniCredit tech infrastructure joint venture from IBM. IBM will supply modernized platforms including IBM Z. Transaction subject to regulatory approvals.